Dr. Stuart Titus sat down with Everett Jolly of Uptick Newswire this week to discuss the ever increasing momentum driving marijuana legalization and the growth of the cannabis industry.
Dr. Titus began the interview relaying recent accomplishments by Medical Marijuana, Inc. and our portfolio of investment companies. This included discussing the potential of HempMeds® Brasil, our local distribution branch in the country. HempMeds® Brasil recently signed a deal with Paragon HealthCare BR to increase opportunities for distribution of RSHO™ and expand the brand’s presence in Brazil.
The interview then moved to recent legalization efforts for both recreational and medical use of cannabis and the implications these endeavours have for the industry. With the soaring popularity of cannabinoids here in the U.S. and worldwide, there is incredible opportunity for companies like Medical Marijuana, Inc. to be able to provide legal cannabinoids to the market.
Next, Dr. Titus moved on to providing updates on the recent achievements of Medical Marijuana, Inc.’s investment companies, including new products being added to the HempMeds® Brasil store, the upcoming one year anniversary of HempMeds® Mexico, and clinical trials on AXIM® Biotechnologies’ CanChew® Plus CBD chewing gum for the treatment of irritable bowel syndrome (IBS), among others developments among our companies.
Follow our news feed to stay current on the progress of Medical Marijuana, Inc. and our portfolio of investments.
